Edition:
United Kingdom

Constellation Pharmaceuticals Inc (CNST.OQ)

CNST.OQ on NASDAQ Stock Exchange Global Select Market

11.93USD
15 Feb 2019
Change (% chg)

$0.59 (+5.20%)
Prev Close
$11.34
Open
$11.22
Day's High
$11.93
Day's Low
$10.51
Volume
12,485
Avg. Vol
8,192
52-wk High
$12.28
52-wk Low
$4.01

Latest Key Developments (Source: Significant Developments)

Constellation Pharma Inc Says Post-IPO Cash Expected To Fund Operations Into Q2 2020
Monday, 7 Jan 2019 

Jan 7 (Reuters) - Constellation Pharmaceuticals Inc ::CONSTELLATION PHARMACEUTICALS INC - POST-IPO CASH EXPECTED TO FUND OPERATIONS INTO Q2 2020.  Full Article

Constellation Pharma Initiates Phase 2 Portion Of Prostar Clinical Trial In Patients With Type Of Prostate Cancer
Monday, 10 Dec 2018 

Dec 10 (Reuters) - Constellation Pharmaceuticals Inc ::CONSTELLATION PHARMACEUTICALS INITIATES PHASE 2 PORTION OF PROSTAR CLINICAL TRIAL IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC).CONSTELLATION PHARMACEUTICALS INC - PRELIMINARY PHASE 1B RESULTS SUGGEST CPI-1205 IS WELL-TOLERATED.CONSTELLATION PHARMACEUTICALS INC - CONTINUES TO EXPECT TO DETERMINE PROOF OF CONCEPT FOR CPI-1205 IN MID-2019..  Full Article

Constellation Pharmaceuticals Reports Q3 Loss Per Share Of $0.81
Thursday, 8 Nov 2018 

Nov 8 (Reuters) - Constellation Pharmaceuticals Inc ::CONSTELLATION PHARMACEUTICALS ANNOUNCES THIRD-QUARTER AND NINE-MONTH 2018 FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.81.Q3 EARNINGS PER SHARE VIEW $-0.67 -- THOMSON REUTERS I/B/E/S.EXPECTS TO EVALUATE PROOF OF CONCEPT FOR CPI-1205 AND CPI-0610 PROGRAMS IN MID-2019.CONSTELLATION PHARMACEUTICALS - EXPECT CASH AS OF SEPT 30, 2018, WILL FUND PLANNED OPERATIONS INTO Q1 2020.  Full Article

Constellation Pharmaceuticals Shares Debut At $11.48, About 23 Pct Below IPO Price
Thursday, 19 Jul 2018 

July 19 (Reuters) - :CONSTELLATION PHARMACEUTICALS SHARES DEBUT AT $11.48 ON NASDAQ VERSUS IPO PRICE OF $15.00/SHARE.  Full Article

Constellation Pharmaceuticals Announces Pricing Of Initial Public Offering
Thursday, 19 Jul 2018 

July 18 (Reuters) - Constellation Pharmaceuticals Inc ::CONSTELLATION PHARMACEUTICALS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING.SAYS INITIAL PUBLIC OFFERING OF 4.00 MILLION COMMON SHARES PRICED AT $15.00PER SHARE.  Full Article

Constellation Pharma Sees IPO Of 5.3 Mln Shares Priced $14-$16 Per Share
Monday, 9 Jul 2018 

July 9 (Reuters) - Constellation Pharmaceuticals Inc ::CONSTELLATION PHARMACEUTICALS INC - SEES IPO OF 5.3 MILLION SHARES OF COMMON STOCK PRICED BETWEEN $14.00 AND $16.00 PER SHARE.  Full Article